- Home
- AERO vs VCYT Comparison
AERO vs VCYT Comparison
Compare AERO & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AERO | VCYT |
|---|---|---|
| Founded | 1934 | 2006 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | AERO | VCYT |
|---|---|---|
| Price | $19.41 | $35.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $30.83 | ★ $46.00 |
| AVG Volume (30 Days) | 331.0K | ★ 738.4K |
| Earning Date | 01-01-0001 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 130.39 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | N/A |
| Revenue This Year | $7.14 | $16.72 |
| Revenue Next Year | $4.82 | $11.27 |
| P/E Ratio | ★ $7.95 | $111.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.00 | $22.61 |
| 52 Week High | $23.05 | $50.71 |
Technical Indicators
Market Signals| Indicator | AERO | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 38.77 |
| Support Level | $18.91 | $32.51 |
| Resistance Level | $19.66 | $37.24 |
| Average True Range (ATR) | 1.12 | 1.52 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 39.09 | 43.23 |
Price Performance
Historical ComparisonAbout AERO Grupo Aeromexico S.A.B.
Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.